Vasopressin : novel roles for a new hormone – Emerging therapies in cardiometabolic and renal diseases
Melander, O. LU
(2017)
In Journal of Internal Medicine
282(4).
p.281-283
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/f64751e6-40a3-4ded-8e5c-86d540e728aa
- author
- Melander, O.
LU
- organization
- publishing date
- 2017-10-01
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- cardiometabolic, copeptin, renal, vasopressin
- in
- Journal of Internal Medicine
- volume
- 282
- issue
- 4
- pages
- 281 - 283
- publisher
- Wiley-Blackwell
- external identifiers
-
- pmid:28929632
- wos:000411202600001
- scopus:85029676356
- ISSN
- 0954-6820
- DOI
- 10.1111/joim.12656
- language
- English
- LU publication?
- yes
- id
- f64751e6-40a3-4ded-8e5c-86d540e728aa
- date added to LUP
- 2017-10-06 10:44:44
- date last changed
- 2024-03-14 02:48:45
@article{f64751e6-40a3-4ded-8e5c-86d540e728aa,
author = {{Melander, O.}},
issn = {{0954-6820}},
keywords = {{cardiometabolic; copeptin; renal; vasopressin}},
language = {{eng}},
month = {{10}},
number = {{4}},
pages = {{281--283}},
publisher = {{Wiley-Blackwell}},
series = {{Journal of Internal Medicine}},
title = {{Vasopressin : novel roles for a new hormone – Emerging therapies in cardiometabolic and renal diseases}},
url = {{http://dx.doi.org/10.1111/joim.12656}},
doi = {{10.1111/joim.12656}},
volume = {{282}},
year = {{2017}},
}